LEE011 hydrochloride (CAS No 1211443-80-9) is a potent cyclin-dependent kinase 4/6 (CDK4/6) inhibitor primarily utilized in oncology research It originates from the need to halt the progression of cancer cells by disrupting the cell cycle targeting the CDK4/6-Rb pathway In vitro LEE011 hydrochloride demonstrates efficacy in the nanomolar to low micromolar range effectively inhibiting cell proliferation across various cancer cell lines It is frequently employed in cell models and animal studies to evaluate its therapeutic potential and synergy with other anticancer agents Additionally this compound is widely used in drug screening and preclinical trials to assess its viability as a treatment option Experimental concentrations typically depend on the specific research design ensuring its application is tailored to the desired outcomes in scientific investigations